BriaCell is advancing a new generation of cancer immunotherapies designed to improve outcomes for patients with metastatic breast cancer and other solid tu...
While we will need to wait for the National Commission into the Regulation of AI in Healthcare's recommendations later this summer, and then the MH...
At ASCO, Dr. Nina Balanchivadze of Sarah Cannon Research Institute at Virginia Oncology Associates and Dr. Kyle Lavin of the UNC School of Medicine shared ...
As biopharmaceutical innovation continues to evolve, analytical science is playing a more strategic role in accelerating development and supporting regulat...
New registry will generate robust real-world evidence on disease burden, treatment patterns and long-term effectiveness of newly approved and emerging th...
Leading regenerative medicine innovators unite to deliver seamless stem cell banking and personalized biologic solutions for physicians and patients nati...
As drug development becomes increasingly complex, early-phase clinical trials are taking on a far more strategic role than simply establish...
As pharmaceutical manufacturers face increasing pressure to maintain production continuity, ensure regulatory compliance, and manage ageing equipment, the ...
The promise of precision oncology depends not only on scientific innovation but also on successful implementation in routine clinical practice. Drawing on ...
As oncology practices face increasing patient demand and looming workforce shortages, advanced practice providers (APPs) are becoming an essential part of ...
As oncology care becomes increasingly personalized and technology-enabled, digital tools are playing a growing role in improving patient outcomes beyond th...
Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, introd...
First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with ch...
As healthcare systems around the world grapple with rising costs, growing chronic disease burdens, and increasing demand for innovative therapies, biosimil...
© 2026 Biopharma Boardroom. All Rights Reserved.
